Canopy Growth, Indivior, and Tilray are the three Cannabis stocks to watch today, according to MarketBeat's stock screener tool. Error: Response status code does not indicate success: 429 (Too Many Requests). These companies had the highest dollar trading volume of any Cannabis stocks within the last several days.
Canopy Growth (CGC)
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.
CGC traded down $0.14 during midday trading on Monday, reaching $1.28. 5,447,661 shares of the company's stock were exchanged, compared to its average volume of 6,728,680. Canopy Growth has a 1-year low of $0.77 and a 1-year high of $14.92. The company has a debt-to-equity ratio of 0.74, a current ratio of 3.52 and a quick ratio of 2.58. The business's 50-day moving average price is $1.16 and its 200 day moving average price is $2.54. The stock has a market capitalization of $234.43 million, a PE ratio of -0.34 and a beta of 0.92.
Read Our Latest Research Report on CGC
Indivior (INDV)
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Shares of INDV stock traded up $0.11 during mid-day trading on Monday, hitting $11.67. 558,821 shares of the company's stock were exchanged, compared to its average volume of 968,861. The stock has a 50-day simple moving average of $9.48 and a two-hundred day simple moving average of $10.34. Indivior has a fifty-two week low of $7.33 and a fifty-two week high of $18.59. The stock has a market cap of $1.61 billion, a price-to-earnings ratio of -33.44 and a beta of 0.93.
Read Our Latest Research Report on INDV
Tilray (TLRY)
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.
Shares of NASDAQ TLRY traded down $0.02 on Monday, reaching $0.47. 9,050,222 shares of the company traded hands, compared to its average volume of 29,450,971. Tilray has a fifty-two week low of $0.43 and a fifty-two week high of $2.52. The company has a current ratio of 2.54, a quick ratio of 1.58 and a debt-to-equity ratio of 0.10. The company has a 50 day moving average of $0.62 and a 200 day moving average of $1.08. The stock has a market capitalization of $475.07 million, a PE ratio of -1.56 and a beta of 1.88.
Read Our Latest Research Report on TLRY
See Also
Before you consider Canopy Growth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.
While Canopy Growth currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
